Considerable disagreement among definitions of metabolic syndrome for Japanese

Circulation Journal

Volumn 71, Issue 8, 2007, Pages 1239-1243

  Oda, Eiji ^a   Abe, Masahiro ^a   Veeraveedu, Punniyakoti T ^b   Watanabe, Kenichi ^b  

^a Niigata Prefectural Yoshida Hospital   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Diagnosis; Inflammation; Metabolic syndrome; Obesity; Risk factors

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

C-REACTIVE PROTEIN; DISSENT AND DISPUTES; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; OBESITY; TERMINOLOGY;

EID: 34547575893     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1239     Document Type: Article

References (37)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005: 111: 1448-1454.
3. DeFronzo RA, Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
4. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition: A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
5. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-1247.
6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: A statement for health care professionals: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
7. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304.
8. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
9. Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: The Hisayama Study. Diabetes Care 2005; 28: 2497-2500.
10. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825.
11. Oda E. Criteria for diagnosing the metabolic syndrome (Letter). Am J Clin Nutr 2006; 84: 1251-1252.
12. Oda E. The metabolic syndrome (emperor) wears no clothes (Letter). Diabetes Care 2006; 29: 2566.
13. Oda E. Metabolic syndrome and CRP (Letter). Circ J 2007; 71: 620.
14. The Examination Committee of Criteria for Metabolic Syndrome. The definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 2005; 94: 794-809 (in Japanese).
15. Kiyohara Y, Doi Y, Ninomiya T. Actual evidence of metabolic syndrome. J Jpn Soc Intern Med 2006; 95: 1710-1715 (in Japanese).
16. Oda E, Oohara K, Abe A, Veeraveedu PT, Watanabe K, Kato K, et al. The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan. Circ J 2006; 70: 384-388.
17. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
18. Yeh ET, Willerson JT. Coming of age of C-reactive protein: Using inflammation markers in cardiology. Circulation 2003; 107: 370-372.
19. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Kishi R. Metabolic syndrome, C-reactive protein and increased arterial stiffness in Japanese subjects. Hypertens Res 2006; 29: 589-596.
20. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: The Minoh Study. Circ J 2005; 69: 386-391.
21. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Naga N, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001; 153: 1183-1190.
22. Ishikawa S, Kayaba K, Gotoh T, Nakamura Y, Kajii E. Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study. Circ J 2007; 71: 26-31.
23. Kayaba K, Ishikawa S, Gotoh T, Naga N, Kajii E, Nakamura Y, et al. Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: The Jichi Medical School Cohort Study at Yamato, 1993-1998. Jpn Circ J 2000; 64: 303-308.
24. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
25. Oda E. n-3 Fatty acids and the endocannabinoid system (Letter). Am J Clin Nutr 2007; 85: 919.
26. The Examination Committee of Criteria for "Obesity Disease" in Japan, the Japanese Society for the Study of Obesity. New Criteria for "Obesity Disease" in Japan. Circ J 2002; 66: 987-992.
27. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: A new worldwide definition. The Lancet 2005; 366: 1059-1062.
28. Oda E. Cut points of waist circumference for Japanese people (Letter). Diabet Med 2006; 23: 1385.
29. Alberti KG, Zimmet P, Shaw J. Cut points of waist circumference for Japanese people (Reply). Diabet Med 2006; 23: 1385-1386.
30. Oda E. Cut points of waist circumference (Letter). Diabetes Care 2006; 29: 1188-1189.
31. Sone H, Tanaka S, Ohashi Y, Yamada N. Cut points of waist circumference (Letter). Diabetes Care 2006; 29: 1189.
32. Oda E. Japanese criteria of metabolic syndrome (Letter). Circ J 2006; 70: 364.
33. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome. Diabetes Care 2007; 30: 120-127.
34. Shamsuzzaman ASM, Winnicki M, Wolk R, Svatikova A, Phillips BG, Davison DE, et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 2004; 109: 2181-2185.
35. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Zhang H, et al. Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis 2006; 188: 184-189.
36. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007; 75: 72-80.
37. Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 2006; 29: 1123-1124.